Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 16/20 | 0.37 |
| ▸ | PTGS1 | P23219 | 6/20 | 0.35 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.35 |
| ▸ | FEN1 | P39748 | 1/20 | 0.34 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20111216 | 0.84 | CTSL (0.39) | PTGS2PTGS1RIPK1FEN1 | |
| SCHEMBL1547626 | 0.80 | RIPK1 (0.47) | RIPK1P2RX7 | |
| SCHEMBL20117594 | 0.77 | NQO1 (0.35) | FEN1 | |
| SCHEMBL15471665 | 0.75 | CTSS (0.42) | RIPK1FEN1 | |
| SCHEMBL20102397 | 0.74 | CTSL (0.39) | FEN1 | |
| SCHEMBL19196278 | 0.74 | GABRA1 (0.39) | RIPK1FEN1P2RX7 | |
| SCHEMBL20169915 | 0.72 | CTSS (0.42) | RIPK1 | |
| SCHEMBL16933827 | 0.72 | HEXA (0.40) | PTGS2PTGS1P2RX7 | |
| SCHEMBL19193286 | 0.71 | RIPK1 (0.38) | RIPK1FEN1P2RX7 | |
| SCHEMBL8097082 | 0.71 | RIPK1 (0.38) | RIPK1P2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10323187-B2 | Liquid crystal compound having biphenylene, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2019-06-18 | — | — | US | disclosed |
| US-20180119009-A1 | LIQUID CRYSTAL COMPOUND HAVING BIPHENYLENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2018-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180119009-A1 | LIQUID CRYSTAL COMPOUND HAVING BIPHENYLENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | YBX1, PIEZO1, C1S | PTGS2 4062/4885PTGS1 3924/4885RIPK1 1596/4885 |
| US-10323187-B2 | Liquid crystal compound having biphenylene, liquid crystal composition and liquid crystal display device | YBX1, PIEZO1, C1S | PTGS2 4062/4885PTGS1 3924/4885RIPK1 1596/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.